Posts

Tesla brings its robotaxi service to Dallas and Houston

Tesla is expanding its robotaxi service to Dallas and Houston, according to a social media post from the company. The post says simply that “Robotaxi is now rolling out in Dallas & Houston 🤠” and includes a 14-second video showing Tesla vehicles driving without human monitors or drivers in the front seat. The company now […]

AI chip startup Cerebras files for IPO

In recent months, the company announced an agreement with Amazon Web Services to use Cerebras chips in Amazon data centers, as well as a deal with OpenAI reportedly worth more than $10 billion.

Sources: Cursor in talks to raise $2B+ at $50B valuation as enterprise growth surges

Returning backers a16z and Thrive are expected to lead the round.

Hackers are abusing unpatched Windows security flaws to hack into organizations

A security researcher published details of three security vulnerabilities in Windows Defender, and the code used to exploit them. Now, hackers are taking advantage of the vulnerabilities in real-life attacks, according to a cybersecurity firm.

OpenAI takes aim at Anthropic with beefed-up Codex that gives it more power over your desktop

OpenAI's agentic coding tool has gotten a major makeover, with a variety of new powers and abilities.

Anthropic CPO leaves Figma’s board after reports he will offer a competing product

Krieger's departure and any forthcoming design tools will be another data point for investors who fear the SaaSpocalypse — that the largest AI labs will come to dominate software businesses, a thesis that has rocked public markets at times this year.

Aloe Blacc’s fame means nothing in biotech (and that’s the point)

When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]